The Department of Veterans Affairs (VA) and IBM Watson Health have announced the extension of a public-private partnership to apply artificial intelligence (AI) to help interpret cancer data in the treatment of veteran patients. First announced two years ago as part of the National Cancer Moonshot Initiative, VA oncologists have now used IBM Watson for Genomics technology to support precision oncology care for more than 2,700 Veterans with cancer. Precision oncology is the practice of biologically directed cancer care. VA's precision oncology program primarily supports stage 4 cancer patients who have exhausted other treatment options. The partnership extension with IBM will enable VA oncologists to continue using Watson for Genomics through at least June 2019. For more information about the VA's precision oncology program, visit the VA Office of Research and Development website.
For more on veteran benefits, visit the Military.com Benefits Center.
